Edwards Lifesciences says TAVR drove 12% sales growth in Q3

Edwards Lifesciences reported Q3 results that met Wall Street expectations. It remains on track to boost sales by up to 13% this year. 

Related Keywords

Japan ,California ,United States ,San Francisco ,Irvine ,Japanese ,Edwards Lifesciences ,Bernard Zovighian ,Larry Wood ,European Commission ,European Union ,Wall Street ,Cardiovascular Therapeutics ,Pascal Precision ,